Research ExplorerJournalsEUR UROL Publications

EUR UROL - European urology

251 - 281 out of 281Page size: 50

Publications

  1. 2007

  2. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.

    Briganti, A., Karakiewicz, P. I., Chun, F., Gallina, A., Salonia, A., Zanni, G., Valiquette, L., Graefen, M., Huland, H., Rigatti, P. & Montorsi, F., 2007, In: EUR UROL. 51, 6, p. 1573-1581 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

    Gallina, A., Jeldres, C., Chun, F., Shariat, S. F., Briganti, A., Walz, J., Roehrborn, C. G., Saad, F., Huland, H., Graefen, M., Montorsi, F. & Karakiewicz, P. I., 2007, In: EUR UROL. 52, 5, p. 1374-1380 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.

    Briganti, A., Fabbri, F., Salonia, A., Gallina, A., Chun, F., Dehò, F., Zanni, G., Suardi, N., Karakiewicz, P. I., Rigatti, P. & Montorsi, F., 2007, In: EUR UROL. 52, 3, p. 702-707 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

    Chun, F., Briganti, A., Gallina, A., Hutterer, G. C., Shariat, S. F., Antebie, E., Walz, J., Roehrborn, C. G., Salonia, A., Rigatti, P., Saad, F., Huland, H., Montorsi, F., Graefen, M. & Karakiewicz, P. I., 2007, In: EUR UROL. 52, 4, p. 1067-1074 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

    Briganti, A., Chun, F., Hutterer, G. C., Gallina, A., Shariat, S. F., Salonia, A., Scattoni, V., Valiquette, L., Montorsi, F., Rigatti, P., Graefen, M., Huland, H. & Karakiewicz, P. I., 2007, In: EUR UROL. 52, 3, p. 733-743 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

    Chun, F., Briganti, A., Jeldres, C., Erbersdobler, A., Schlomm, T., Steuber, T., Gallina, A., Walz, J., Perrotte, P., Huland, H., Graefen, M. & Karakiewicz, P. I., 2007, In: EUR UROL. 51, 4, p. 949-955 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2006

  9. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.

    Chun, F. K-H., Steuber, T., Erbersdobler, A., Currlin, E., Walz, J., Schlomm, T., Haese, A., Heinzer, H., McCormack, M., Huland, H., Graefen, M. & Karakiewicz, P. I., 2006, In: EUR UROL. 49, 5, p. 820-826 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.

    Eichelberg, C., Erbersdobler, A., Haese, A., Schlomm, T., Chun, F. K. H., Currlin, E., Walz, J., Steuber, T., Graefen, M. & Huland, H., 2006, In: EUR UROL. 49, 6, p. 1011-1018 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.

    Walz, J., Graefen, M., Chun, F. K-H., Erbersdobler, A., Haese, A., Steuber, T., Schlomm, T., Huland, H. & Karakiewicz, P. I., 2006, In: EUR UROL. 50, 3, p. 498-505 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.

    Chun, F. K-H., Briganti, A., Lebeau, T., Fradet, V., Steuber, T., Walz, J., Schlomm, T., Eichelberg, C., Haese, A., Erbersdobler, A., McCormack, M., Perrotte, P., Graefen, M., Huland, H. & Karakiewicz, P. I., 2006, In: EUR UROL. 49, 2, p. 273-279 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Transperitoneal laparoscopic adrenalectomy: outline of the preoperative management, surgical approach, and outcome.

    Zacharias, M., Haese, A., Jurczok, A., Stolzenburg, J-U. & Fornara, P., 2006, In: EUR UROL. 49, 3, p. 448-459 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2005

  15. Guidelines on testicular cancer

    Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Horwich, A., Klepp, O., Laguna, M. P. & Pizzocaro, G., 12.2005, In: EUR UROL. 48, 6, p. 885-94 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.

    Maas, R., Wenske, S., Zabel, M., Ventura, R., Schwedhelm, E., Steenpass, A., Klemm, H., Noldus, J. & Böger, R. H., 2005, In: EUR UROL. 48, 6, p. 1002-1004 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.

    Palisaar, R-J., Noldus, J., Graefen, M., Erbersdobler, A., Haese, A. & Huland, H., 2005, In: EUR UROL. 47, 2, p. 176-184 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?

    Graefen, M., Walz, J., Chun, K-H. F., Schlomm, T., Haese, A. & Huland, H., 2005, In: EUR UROL. 47, 6, p. 756-760 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2004

  20. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.

    Friedrich, M., Toma, M. I., Petri, S., Cheng, J. C., Hammerer, P., Erbersdobler, A. & Huland, H., 2004, In: EUR UROL. 45, 6, p. 737-743 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.

    Hautmann, S., Toma, M., Gomez, L., Friedrich, M., Friedrich, M. G., Jaekel, T., Michl, U., Schroeder, G. L., Huland, H., Juenemann, K-P. & Lokeshwar, V. B., 2004, In: EUR UROL. 46, 4, p. 466-471 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched-pair analysis.

    Köllermann, J., Hopfenmüller, W., Caprano, J., Anke, B., Weidenfeld, H., Weidenfeld, M. & Helpap, B., 2004, In: EUR UROL. 45, 1, p. 42-45 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. 2003

  24. Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?

    Friedrich, M., Hellstern, A., Toma, M. I., Hammerer, P. & Huland, H., 2003, In: EUR UROL. 43, 2, p. 141-146 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.

    Graefen, M., Augustin, H., Karakiewicz, P. I., Hammerer, P. G., Haese, A., Palisaar, J., Blonski, J., Fernandez, S., Erbersdobler, A. & Huland, H., 2003, In: EUR UROL. 43, 1, p. 6-11 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patients.

    Köllermann, J., Müller, M., Goessl, C., Krause, H., Helpap, B., Pantel, K. & Miller, K., 2003, In: EUR UROL. 44, 5, p. 533-538 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. 2002

  28. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.

    Palisaar, R. J., Graefen, M., Karakiewicz, P. I., Hammerer, P. G., Huland, E., Haese, A., Fernandez, S., Erbersdobler, A., Henke, R-P. & Huland, H., 2002, In: EUR UROL. 41, 2, p. 155-161 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy.

    Noldus, J., Michl, U., Graefen, M., Haese, A., Hammerer, P. & Huland, H., 2002, In: EUR UROL. 42, 2, p. 118-124 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. 2001

  31. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.

    Friedrich, M., Blind, C., Milde-Langosch, K., Erbersdobler, A., Conrad, S., Löning, T., Hammerer, P. & Huland, H., 2001, In: EUR UROL. 40, 5, p. 518-524 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Neuroendocrine differentiation and short-term neoadjuvant hormonal treatment of prostatic carcinoma with special regard to tumor regression.

    Köllermann, J. & Helpap, B., 2001, In: EUR UROL. 40, 3, p. 313-317 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder.

    Friedrich, M., Riethdorf, S., Erbersdobler, A., Tiemer, C., Schwaibold, H., Sölter, J. K., Huland, E., Riethdorf, L., Conrad, S., Hammerer, P. G. & Huland, H., 2001, In: EUR UROL. 39, 2, p. 159-166 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. 2000

  35. Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma.

    Köllermann, J., Feek, U., Müller, H., Kaulfuss, U., Oehler, U., Helpap, B. & Köllermann, M. W., 2000, In: EUR UROL. 38, 6, p. 714-720 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Stage migration in clinically localized prostate cancer.

    Noldus, J., Graefen, M., Haese, A., Henke, R. P., Hammerer, P. & Huland, H., 2000, In: EUR UROL. 38, 1, p. 74-78 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. 1999

  38. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

    Graefen, M., Noldus, J., Pichlmeier, U., Haese, A., Hammerer, P., Fernandez, S., Conrad, S., Henke, R., Huland, E. & Huland, H., 1999, In: EUR UROL. 36, 1, p. 21-30 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. 1998

  40. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.

    Schlechte, H., Lenk, S. V., Löning, T., Schnorr, D., Rudolph, B. D., Ditscherlein, G. & Loening, S. A., 1998, In: EUR UROL. 34, 5, p. 433-440 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Supersensitive PSA-monitored neoadjuvant hormone treatment of clinically localized prostate cancer: effects on positive margins, tumor detection and epithelial cells in bone marrow.

    Köllermann, M. W., Pantel, K., Enzmann, T., Feek, U., Köllermann, J., Kossiwakis, M., Kaulfuss, U., Martell, W. & Spitz, J., 1998, In: EUR UROL. 34, 4, p. 318-324 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 12 3 4 5 6 Next